Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.5.3, indicating a new build of the ClinicalTrials.gov page. No changes to the study details or eligibility information are evident.
    Difference
    0.1%
    Check dated 2026-04-30T18:28:20.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision banner updated to v3.5.2; the previous v3.5.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:30:58.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-25T19:58:41.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T05:11:28.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-17T21:11:51.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added. The notices about government funding lapse and the previous Revision: v3.4.0 were removed.
    Difference
    0.4%
    Check dated 2026-02-09T14:54:54.000Z thumbnail image

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.